Icici Lombard General Insurance Company Ltd vs Niva Bupa Health Insurance Company Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jul 29, 2026

Key Highlights

The Latest Trading Price of ICICI Lombard General Insurance Company Ltd is ₹ 1650 as of 29 Jul 14:23 . The P/E Ratio of ICICI Lombard General Insurance Company Ltd changed from 44.3 on March 2021 to 30.8 on March 2026 . This represents a CAGR of -5.88% over 6 yearsThe P/E Ratio of Niva Bupa Health Insurance Company Ltd changed from 66.7 on March 2025 to 98.8 on March 2026 . This represents a CAGR of 21.71% over 2 years The Market Cap of ICICI Lombard General Insurance Company Ltd changed from ₹ 65270 crore on March 2021 to ₹ 85265 crore on March 2026 . This represents a CAGR of 4.55% over 6 yearsThe Market Cap of Niva Bupa Health Insurance Company Ltd changed from ₹ 14252 crore on March 2025 to ₹ 12954 crore on March 2026 . This represents a CAGR of -4.66% over 2 years The revenue of ICICI Lombard General Insurance Company Ltd for the Jun '26 is ₹ 7101 crore as compare to the Mar '26 revenue of ₹ 6856 crore. This represent the growth of 3.58% The revenue of Niva Bupa Health Insurance Company Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 2114 crore. This represent the decline of -100% The ebitda of ICICI Lombard General Insurance Company Ltd for the Jun '26 is ₹ 535.7 crore as compare to the Mar '26 ebitda of ₹ 718.2 crore. This represent the decline of -25.41% The ebitda of Niva Bupa Health Insurance Company Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 341.16 crore. This represent the decline of -100% The net profit of ICICI Lombard General Insurance Company Ltd changed from ₹ 580.37 crore to ₹ 403.17 crore over 9 quarters. This represents a CAGR of -14.95% The net profit of Niva Bupa Health Insurance Company Ltd changed from ₹ -18.82 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of ICICI Lombard General Insurance Company Ltd changed from 24.69 % on March 2021 to 24.28 % on March 2026 . This represents a CAGR of -0.28% over 6 yearsThe Dividend Payout of Niva Bupa Health Insurance Company Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About ICICI Lombard General Insurance Company Ltd

ICICI Lombard General Insurance Company Limited is the largest private-sector non-life insurer in India based on Gross Direct Premium Income.
The Company offers its customers a comprehensive and well-diversified range of products, including Fire, Motor, Health, PA & Travel, Crop, Marine, Engineering and Liability insurance, through multiple distribution channels.
The key distribution channels of the Company include direct sales, individual agents, bank partners, other corporate agents, brokers, and online, through which the Company service its individual, corporate and government customers. ICICI Lombard General Insurance Company Limited was incorporated on October 30, 2000 as a Public Limited Company.
The Company obtained the Certificate of Commencement of Business on January 11, 2001 from the Registrar of Companies, Mumbai.

About Niva Bupa Health Insurance Company Ltd

Niva Bupa Health Insurance Company Limited was initially incorporated as Max Bupa Health Insurance Limited' at New Delhi, Delhi as a Public Limited Company dated September 5, 2008 and granted its Certificate for Commencement of Business on December 23, 2008 by the Deputy Registrar of Companies, NCT of Delhi and Haryana.
Thereafter, Company changed its name to Max Bupa Health Insurance Company Limited', dated July 30, 2009 and again to Niva Bupa Health Insurance Company Limited' pursuant to a fresh Certificate of Incorporation dated July 5, 2021 issued by the Registrar of Companies, Delhi. The Company is a standalone health insurer (SAHI) strategically focused on the retail health market.
The Company underwrites primarily Health Insurance business which includes Personal accident, Critical illness and Travel.

FAQs for the comparison of ICICI Lombard General Insurance Company Ltd and Niva Bupa Health Insurance Company Ltd

Which company has a larger market capitalization, ICICI Lombard General Insurance Company Ltd or Niva Bupa Health Insurance Company Ltd?

Market cap of ICICI Lombard General Insurance Company Ltd is 84,019 Cr while Market cap of Niva Bupa Health Insurance Company Ltd is 15,999 Cr

What are the key factors driving the stock performance of ICICI Lombard General Insurance Company Ltd and Niva Bupa Health Insurance Company Ltd?

The stock performance of ICICI Lombard General Insurance Company Ltd and Niva Bupa Health Insurance Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ICICI Lombard General Insurance Company Ltd and Niva Bupa Health Insurance Company Ltd?

As of July 29, 2026, the ICICI Lombard General Insurance Company Ltd stock price is INR ₹1682.55. On the other hand, Niva Bupa Health Insurance Company Ltd stock price is INR ₹86.52.

How do dividend payouts of ICICI Lombard General Insurance Company Ltd and Niva Bupa Health Insurance Company Ltd compare?

To compare the dividend payouts of ICICI Lombard General Insurance Company Ltd and Niva Bupa Health Insurance Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.